Rockefeller Capital Management
COYA icon

Rockefeller Capital Management’s Coya Therapeutics COYA Stock Holding History

Rockefeller Capital Management’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.88K Buy
2,000
+500
+33% +$2.34K ﹤0.01% 4091
2025
Q4 		$8.7K Buy
1,500
+1,000
+200% +$6.08K ﹤0.01% 3863
2025
Q3 		$2.85K Buy
+500
New +$3.04K ﹤0.01% 4021

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Rockefeller Capital Management's COYA Position: Q1 2026 in Review

Rockefeller Capital Management increased its Coya Therapeutics (COYA) stake by 33% in Q1 2026, buying an estimated $2.34K and bringing the position to 2,000 shares worth $7.88K. The position accounts for ﹤0.01% of the portfolio, ranked #4091.

Rockefeller Capital Management first reported a position in COYA in Q3 2025 and has held it in 3 quarters since. The position peaked at $8.7K in Q4 2025. 56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

  • Rockefeller Capital Management held 2,000 shares of Coya Therapeutics worth $7.88K as of Q1 2026.
  • Rockefeller Capital Management bought 500 Coya Therapeutics shares in Q1 2026, an estimated $2.34K.
  • Coya Therapeutics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4091 holding.
  • Rockefeller Capital Management first reported a position in Coya Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Rockefeller Capital Management's Coya Therapeutics position peaked at $8.7K in Q4 2025.
  • 56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.